Literature DB >> 6276287

The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.

F Takeuchi, F Hanaoka, E Yano, M Yamada, Y Horiuchi, I Akaoka.   

Abstract

The mode of genetic transmission of gout and increased activity of phosphoribosylphrophosphate synthetase (PRPPS) was studied in one family. Among 15 members of Family F, two male members had gout and had PRPPS activity of erythrocyte lysates three times higher than normal subjects. Five female members had activity 2.5 times higher than normal. The difference between the activities of male and female affected members was statistically significant (P less than 0.05). To examine the genetic trait of this abnormal PRPPS, the incorporation of 3H-adenine into erythrocytes or lymphocytes was studied using autoradiography. The number of grains which show the uptake of labeled adenine into cells revealed a normal distribution pattern in two normal persons and in two male patients, and a mixed pattern of the two cell populations in two female affected members. These results suggested mosaicism in female members and X-linked dominant transmission of this trait. Thermal inactivation of PRPPS of an affected female was intermediate between that from a normal subject and that from the affected males. This result showed the heterogeneity of the PRPPS from the hemolysate of an affected female. The genotype of PRPPS on the X-chromosome was assumed and the lod score between PRPPS and Xg was also estimated. From these findings and electrophoretical study, it was suggested that the abnormal enzyme was a mutant enzyme transmitted in an X-linked dominant trait, and that the mutation occurred on the structural gene of the PRPPS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6276287     DOI: 10.1007/bf00294932

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  The enzymatic spectrophotometric method for determination of uric acid.

Authors:  L LIDDLE; J E SEEGMILLER; L LASTER
Journal:  J Lab Clin Med       Date:  1959-12

2.  Evidence for X-linkage of phosphoribosylpyrophosphate synthetase in man. Studies with cultured fibroblasts from a gouty family with mutant feedback-resistant enzyme.

Authors:  E Zoref; A De Vries; O Sperling
Journal:  Hum Hered       Date:  1977       Impact factor: 0.444

3.  Evidence for X-linkage of human phosphoribosylpyrophosphate synthetase.

Authors:  R C Yen; W B Adams; C Lazar; M A Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

5.  Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity.

Authors:  M A Becker; L J Meyer; J E Seegmiller
Journal:  Am J Med       Date:  1973-08       Impact factor: 4.965

6.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate.

Authors:  W N Valentine; D E Paglia; A P Tartaglia; F Gilsanz
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

8.  A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan.

Authors:  S Miwa; H Fujii; N Matsumoto; T Nakatsuji; S Oda; H Asano; S Asano
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

9.  Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.

Authors:  M A Becker; K O Raivio; B Bakay; W B Adams; W L Nyhan
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

10.  Gene amplification and drug resistance in cultured murine cells.

Authors:  R T Schimke; R J Kaufman; F W Alt; R F Kellems
Journal:  Science       Date:  1978-12-08       Impact factor: 47.728

View more
  3 in total

1.  Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females.

Authors:  Marie Zikánová; Dawn Wahezi; Arielle Hay; Blanka Stiburková; Charles Pitts; Dita Mušálková; Václava Škopová; Veronika Barešová; Olga Soucková; Katerina Hodanová; Martina Živná; Viktor Stránecký; Hana Hartmannová; Ales Hnízda; Anthony J Bleyer; Stanislav Kmoch
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

2.  Rapid method for the diagnosis of partial adenine phosphoribosyltransferase deficiencies causing 2,8-dihydroxyadenine urolithiasis.

Authors:  F Takeuchi; K Matsuta; T Miyamoto; S Enomoto; S Fujimori; I Akaoka; N Kamatani; K Nishioka
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  AR-induced long non-coding RNA LINC01503 facilitates proliferation and metastasis via the SFPQ-FOSL1 axis in nasopharyngeal carcinoma.

Authors:  Shi-Wei He; Cheng Xu; Ying-Qing Li; Ying-Qin Li; Yin Zhao; Pan-Pan Zhang; Yuan Lei; Ye-Lin Liang; Jun-Yan Li; Qian Li; Yang Chen; Sheng-Yan Huang; Jun Ma; Na Liu
Journal:  Oncogene       Date:  2020-07-13       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.